Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$191.17 - $325.63 $348,694 - $593,949
1,824 Added 4.86%
39,347 $12.8 Million
Q4 2023

Feb 13, 2024

SELL
$160.99 - $215.69 $1,609 - $2,156
-10 Reduced 0.03%
37,523 $7.15 Million
Q3 2023

Nov 13, 2023

BUY
$194.33 - $283.97 $3.36 Million - $4.9 Million
17,271 Added 85.24%
37,533 $7.47 Million
Q2 2023

Aug 04, 2023

SELL
$223.05 - $302.68 $56 Million - $76 Million
-250,934 Reduced 92.53%
20,262 $5.78 Million
Q1 2023

May 11, 2023

BUY
$175.41 - $217.92 $43.2 Million - $53.7 Million
246,286 Added 988.7%
271,196 $58.8 Million
Q4 2022

Feb 07, 2023

SELL
$204.38 - $296.82 $220,526 - $320,268
-1,079 Reduced 4.15%
24,910 $5.12 Million
Q3 2022

Nov 10, 2022

SELL
$195.21 - $310.53 $420,677 - $669,192
-2,155 Reduced 7.66%
25,989 $7.23 Million
Q2 2022

Aug 03, 2022

BUY
$115.91 - $214.48 $281,197 - $520,328
2,426 Added 9.43%
28,144 $5.38 Million
Q1 2022

May 04, 2022

BUY
$127.96 - $207.36 $321,563 - $521,095
2,513 Added 10.83%
25,718 $5.33 Million
Q4 2021

Feb 04, 2022

BUY
$165.13 - $241.83 $949,167 - $1.39 Million
5,748 Added 32.93%
23,205 $4.14 Million
Q3 2021

Oct 07, 2021

BUY
$163.99 - $235.57 $283,866 - $407,771
1,731 Added 11.01%
17,457 $3.59 Million
Q2 2021

Aug 04, 2021

BUY
$131.45 - $201.49 $317,451 - $486,598
2,415 Added 18.14%
15,726 $2.98 Million
Q1 2021

May 04, 2021

BUY
$92.73 - $142.05 $440,282 - $674,453
4,748 Added 55.45%
13,311 $1.73 Million
Q4 2020

Feb 02, 2021

BUY
$67.44 - $103.72 $577,488 - $888,154
8,563 New
8,563 $888,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.